Professor Kevin Shakesheff, University of Nottingham

Director

Prof Molly Stevens, Imperial College London

Director

Molly Stevens is Professor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences in the Institute of Biomedical Engineering at Imperial College. She graduated from Bath University and was awarded a PhD from the University of Nottingham in 2001. Molly conducted post-doctoral studies at the Massachusetts Institute of Technology ahead of joining Imperial in 2004.

Molly’s research uses transformative bioengineering approaches to overcome severe limitations in current materials in biosensing and regenerative medicine. A key focus is on understanding and engineering the biomaterial interface using innovative designs and state of the art materials characterisation methods and using highly multidisciplinary approaches from bioengineers, material scientists, chemists, surgeons and biologists.

MahetabHub Pic is a PhD student in the Tissue Engineering group at the University of Nottingham, working on injectable cell delivery.
I received my BSc and MSc degrees in Pharmaceutical Sciences from Cairo University, Egypt, and joined Prof. Kevin Shakesheff’s group at the University of Nottingham as a PhD student in October 2013. I am currently focusing on injectable administration of cellular therapeutics by quantifying effects of administration stresses on various parameters of cellular health. This will allow clinicians to make informed judgments regarding administration requirements for clinical trials, and answer crucial questions regarding potential reasons for failure to deliver sufficient numbers of viable cells. I will be using this information to design simple delivery systems that protect cells during injectable administration for maximum viability and functionality post-injection.
Publication
Amer, M. H., White, L. J. and Shakesheff, K. M. (2015) The effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapies. Journal of Pharmacy and Pharmacology, 67: 640–650. doi: 10.1111/jphp.12362